Investors' Chronicle Chemring, Latin American funds & Paragon Banking: The Companies and Markets Show
Jun 6, 2025
Christopher Akers, a defense industry analyst, breaks down Chemring's impressive half-year performance, highlighting a record order book linked to the UK's strategic defense review. Meanwhile, Mark Robinson, the companies editor, analyses Paragon Banking's stellar financial results and unique market position. The discussion also veers into Latin America, where stock markets are rebounding, with a focus on funds capitalizing on this upward trend despite political uncertainties. It's a captivating look at current market dynamics across various sectors.
AI Snips
Chapters
Transcript
Episode notes
Chemring's Strong Midyear Performance
- Chemring reported better-than-expected half-year results with a record £1.3bn order book.
- The countermeasures and energetics business grew strongly, while sensors and information orders fell notably.
UK Defence Review Benefits Chemring
- The UK Strategic Defence Review highlights major investments in submarines, munitions, and long-range weapons.
- Chemring is positioned to benefit from these investments, especially in missile procurement and digital targeting.
Uncertainty in UK Defence Spending
- UK's defence spending plans remain uncertain despite review ambitions to reach 3% GDP.
- Upcoming government plans will clarify timing and funding, creating opportunities for investors in firms like Chemring.